Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B CellsYunlong Cao, Xiaoliang Sunney Xie, Xiaoran Chai et al.|Cell|2020Cited by 1.4k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic miceLinlin Bao, Chuan Qin|Nature|2020Cited by 1.2k
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common MarmosetJasper Fuk‐Woo Chan, Kwok‐Yung Yuen, Yanfeng Yao et al.|The Journal of Infectious Diseases|2015Cited by 623
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing StrategyShuo Du, Chuan Qin, Yunlong Cao et al.|Cell|2020Cited by 288
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus ChallengeJiaming Lan, Wenjie Tan, Yanfeng Yao et al.|EBioMedicine|2015Cited by 115